文献速递泌尿系结石

体外冲击波碎石术与输尿管镜取石术治疗成人输尿管结石的成本-效用分析

Cost-utility analysis of shockwave lithotripsy vs ureteroscopic stone treatment in adults.
PubMed 文献 · BJU Int · 2022-08-16

基于TISU随机对照试验中613例输尿管结石患者的前瞻性生活质量与资源使用数据,从英国国家医疗服务体系(NHS)视角比较以体外冲击波碎石术(SWL)或输尿管镜取石术(URS)起始的两种诊疗路径的成本-效用。SWL组平均QALY较URS组低0.021(95%CI -0.033至-0.010),平均费用低809英镑(95%CI -1061至-551英镑)。

要点

  • SWL组平均QALY较URS组低0.021,平均费用低809英镑。
  • SWL具有成本效力的概率在支付意愿阈值每QALY 30000英镑时为79%,20000英镑时为98%。
  • 每损失一个QALY的增量成本为39118英镑(成本节省)。

核心结论

  • SWL路径较URS路径QALY更低但费用更少,每损失一个QALY的增量成本为39118英镑(成本节省);决策者需判断所节省的费用是否足以抵偿QALY的损失。

研究设计与样本

  • 基于TISU随机对照试验(ISRCTN 92289221)前瞻性收集的613例输尿管结石患者生活质量与资源使用数据,从英国国家医疗服务体系(NHS)视角开展的成本-效用分析。

主要发现

  • SWL组与URS组平均QALY差值(SWL vs URS)为-0.021(95%CI -0.033至-0.010),平均费用差值为-809英镑(95%CI -1061至-551英镑)。
  • QALY差异相当于6个月期间URS路径患者约多出10个健康日。
  • SWL具有成本效力的概率在每QALY支付意愿阈值30000英镑时为79%,在20000英镑时为98%。

关键数值与推荐

  • 以EuroQol EQ-5D-3L量表计算生活质量数据,结果以增量成本-效用比和成本-效用可接受曲线表示。
  • SWL组平均QALY较URS组低0.021(95%CI -0.033至-0.010),平均费用较URS组低809英镑(95%CI -1061至-551英镑)。
  • 每损失一个QALY的增量成本为39118英镑(成本节省)。

临床怎么用

  • 原文结论指出决策者需判断所节省的费用是否足以抵偿QALY的损失,未据此给出具体推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the cost-effectiveness, resource use implications, quality-adjusted life-years (QALYs) and cost per QALY of care pathways starting with either extracorporeal shockwave lithotripsy (SWL) or with ureteroscopic retrieval (ureteroscopy [URS]) for the management of ureteric stones. PATIENTS AND METHODS: Data on quality of life and resource use for 613 patients, collected prospectively in the Therapeutic Interventions for Stones of the Ureter (TISU) randomized controlled trial (ISRCTN 92289221), were used to assess the cost-effectiveness of two care pathways, SWL and URS. A health provider (UK National Health Service) perspective was adopted to estimate the costs of the interventions and subsequent resource use. Quality-of-life data were calculated using a generic instrument, the EuroQol EQ-5D-3L. Results are expressed as incremental cost-effectiveness ratios and cost-effectiveness acceptability curves. RESULTS: The mean QALY difference (SWL vs URS) was -0.021 (95% confidence interval [CI] -0.033 to -0.010) and the mean cost difference was -£809 (95% CI -£1061 to -£551). The QALY difference translated into approximately 10 more healthy days over the 6-month period for the patients on the URS care pathway. The probabaility that SWL is cost-effective is 79% at a society's willingness to pay (WTP) threshold for 1 QALY of £30,000 and 98% at a WTP threshold of £20,000. CONCLUSION: The SWL pathway results in lower QALYs than URS but costs less. The incremental cost per QALY is £39 118 cost saving per QALY lost, with a 79% probability that SWL would be considered cost-effective at a WTP threshold for 1 QALY of £30 000 and 98% at a WTP threshold of £20 000. Decision-makers need to determine if costs saved justify the loss in QALYs.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Kilonzo MM, Dasgupta R, Thomas R, et al. Cost-utility analysis of shockwave lithotripsy vs ureteroscopic stone treatment in adults. BJU Int. 2022. PMID: 35974700. doi:10.1111/bju.15862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。